The authors of other studies have reported that napabucasin, an inhibitor of STAT3, could eliminate the immunosuppressive ability of mouse MDSCs and human M-MDSCs, and improve the survival rate of mice carrying melanoma [56]. Here, STAT3 is linked to melanoma.